Treatment with exogenous Ngf caused reduction of trigeminal MPNST frequency, while injection of antibodies directed against Ngf reduced serum levels of the bioactive protein resulting in an increased MPNST incidence (Raju et al. 1989; Vinores and Perez-Polo 1980). Here, NGF is linked to malignant peripheral nerve sheath tumor.